NCT04382443View on ClinicalTrials.gov

Oral Colchicine in Argentina to Prevent Restenosis

PHASE4CompletedINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

March 12, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Coronary Artery DiseaseRestenosis of Coronary Artery StentAtherosclerosisAcute Coronary Syndrome
Interventions
DRUG

Colchicine

At the moment of BMS implantation intervention will mean that this group will receive colchicine as described.

Trial Locations (2)

1111

Sanatorio Las Lomas, San Isidro

1126

Sanatorio Otamendi, Ciudad de Buenos Aires

All Listed Sponsors
lead

Centro de estudios en Cardiologia Intervencionista

OTHER

NCT04382443 - Oral Colchicine in Argentina to Prevent Restenosis | Biotech Hunter | Biotech Hunter